SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-044832
Filing Date
2022-08-08
Accepted
2022-08-08 16:58:54
Documents
2
Period of Report
2022-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2810
2 EX-24 DOCUMENT attachment1.htm EX-24 2141
  Complete submission text file 0001209191-22-044832.txt   6434
Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. 2 CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Sarena Francis Willard (Reporting) CIK: 0001423786 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39488 | Film No.: 221145205

Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Issuer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations